Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Working Capital Changes (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Other Working Capital Changes for 11 consecutive years, with -$14.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 198.02% year-over-year to -$14.2 million, compared with a TTM value of -$19.8 million through Dec 2025, down 714.98%, and an annual FY2025 reading of -$19.8 million, down 714.98% over the prior year.
  • Other Working Capital Changes was -$14.2 million for Q4 2025 at Wave Life Sciences, down from $10.6 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $103.0 million in Q2 2023 and bottomed at -$104.8 million in Q3 2023.
  • Average Other Working Capital Changes over 5 years is -$1.0 million, with a median of $611500.0 recorded in 2021.
  • The sharpest move saw Other Working Capital Changes crashed 29375.0% in 2022, then skyrocketed 3197.34% in 2023.
  • Year by year, Other Working Capital Changes stood at $1.4 million in 2021, then soared by 250.25% to $4.9 million in 2022, then tumbled by 204.68% to -$5.1 million in 2023, then surged by 385.31% to $14.5 million in 2024, then tumbled by 198.02% to -$14.2 million in 2025.
  • Business Quant data shows Other Working Capital Changes for WVE at -$14.2 million in Q4 2025, $10.6 million in Q3 2025, and -$16.1 million in Q2 2025.